RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
- Nature. 1998 May 28;393(6683):333-9. doi: 10.1038/30666.
- 1. Receptor Systems and Cell Biology Units, Glaxo Wellcome Medicines Research Centre, Stevenage, Hertfordshire, UK.
Calcitonin-gene-related peptide (CGRP) and Adrenomedullin are related peptides with distinct pharmacological profiles. Here we show that a receptor with seven transmembrane domains, the calcitonin-receptor-like receptor (CRLR), can function as either a CGRP Receptor or an Adrenomedullin receptor, depending on which members of a new family of single-transmembrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expressed. RAMPs are required to transport CRLR to the plasma membrane. RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP Receptor. RAMP2-transported receptors are core-glycosylated and are Adrenomedullin receptors.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: CGRP Receptor
-
target: CGRP ReceptorResearch Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease
-
target: CGRP Receptor
-
target: CGRP Receptor